Login to Your Account



financings NEWS
While it is still early days, the microbiome space is heating up with a number of biotech start-ups appearing on the scene over the past 12 months.
Belgium's Celyad SA (formerly Cardio3 Biosciences SA) followed the footsteps of its European biotech brethren by filing with the SEC for a U.S. IPO.
LONDON – Psioxus Ltd. has raised £25 million (US$38.5 million) in a series C round that will enable the company to fund a phase I trial of its oncolytic virus enadenotucirev (Enad) in combination with an immune checkpoint inhibitor.
More financings Headlines

Cast Your Vote

Has biotech’s bubble burst?: